Culture, Nocardia (Does not include Antibiotic Sensitivity)

Most Nocardia species are susceptible to trimethoprim–sulfamethoxazole; many strains also respond to linezolid, amikacin, imipenem and some cephalosporins. Common alternatives include minocycline, ceftriaxone/cefepime and certain fluoroquinolones, but resistance varies by species. Severe or disseminated infections often require combination therapy and prolonged treatment; isolates should undergo laboratory susceptibility testing to guide antibiotic choice and duration.

The basic laboratory test to identify Nocardia is microscopy using a modified acid‑fast stain (e.g., modified Kinyoun), which reveals weakly acid‑fast, branching, filamentous, Gram‑positive bacilli. Gram stain may show delicate branching filaments, and cultures (slow growing) with biochemical or molecular confirmation are used subsequently. Clinical suspicion guides ordering the modified acid‑fast stain and appropriate cultures.

First-line therapy is trimethoprim–sulfamethoxazole. Severe or disseminated nocardiosis often requires combination therapy (e.g., TMP‑SMX plus amikacin, imipenem, or a third‑generation cephalosporin). Active alternatives include linezolid, minocycline/doxycycline and sometimes moxifloxacin; susceptibility testing guides choice because species differ in resistance. Treatment duration is prolonged, tailored to site (e.g., CNS) and patient factors.

Differentiate by microscopy, staining, culture and growth: Nocardia are branching, filamentous, weakly Gram‑positive rods that are partially acid‑fast on modified stains; they grow aerobically on routine media within days to a week and form dry, chalky colonies. Mycobacteria are non‑branching, strongly acid‑fast bacilli (Ziehl–Neelsen), require specialized media and show much slower growth (often weeks). Clinical syndromes and antibiotic choices also differ.

Nocardia are aerobic, Gram‑positive, branching filamentous bacteria that resemble fungi. They form weakly acid‑fast, beaded filaments with slow growth, often fragmenting into rods and coccoid forms. Soil saprophytes and opportunistic pathogens, they survive intracellularly in macrophages, can cause pulmonary, cutaneous, or disseminated infections—especially in immunocompromised hosts—and typically require prolonged antibiotic therapy.

Treatment for Nocardia is prolonged—typically 6 to 12 months for pulmonary or localized disease. For severe, disseminated, or central nervous system involvement, and for immunocompromised patients, therapy generally extends to at least 12 months and may be longer. Initial intravenous combination therapy is common, then oral antibiotics; duration is individualized by clinical response and follow-up imaging or cultures.